Search

1. Asyouwere (Volume I, Number 7, March 29, 1919)

2. Asyouwere (Volume I, Number 6, March 22, 1919)

3. Asyouwere (Volume I, Number 8, April 5, 1919)

4. Asyouwere (Volume I, Number 9, April 12, 1919)

5. Asyouwere (Volume I, Number 10, April 19, 1919)

6. Asyouwere (Volume I, Number 11, April 26, 1919)

7. Asyouwere (Volume I, Number 13, May 10, 1919)

8. Asyouwere (Volume I, Number 15, May 24, 1919)

9. Asyouwere (Volume I, Number 17, June 7, 1919)

10. Asyouwere (Volume I, Number 20, June 28, 1919)

11. Asyouwere (Volume I, Number 19, June 21, 1919)

12. Asyouwere (Volume I, Number 24, Anniversary Edition, July 12, 1919)

13. The tropics: their resources, people, and future : a description of the tropical lands of Africa, Asia, Central and South America, Australasia and the Pacific; their natural products, scenery, inhabitants and industries, and the possibilities of their future development

Author(s):

Enock, C. Reginald (Charles Reginald), 1868-1970 author

Publication:

New York : Charles Scribner's Sons, 1915

Subject(s):

Geography
Tropical Climate

14. Special protocol assessment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2018

Subject(s):

Clinical Trials as Topic -- standards
Drug Approval
Drug Evaluation, Preclinical -- standards
Research Design
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

15. Enforcement policy--OTC sunscreen drug products marketed without an approved application

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Health Policy
Marketing
Sunscreening Agents
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

16. Acne vulgaris: establishing effectiveness of drugs intended for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Acne Vulgaris -- drug therapy
Drug Evaluation -- standards
Clinical Trials as Topic -- standards
Endpoint Determination
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

17. Anthrax: developing drugs for prophylaxis of inhalational anthrax

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Anthrax -- drug therapy
Anthrax -- prevention & control
Antibiotic Prophylaxis
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Inhalation Exposure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

18. Complicated intra-abdominal infections: developing drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Anti-Bacterial Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation -- standards
Drugs, Investigational -- pharmacokinetics
Intraabdominal Infections -- drug therapy
Microbiological Techniques -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

19. M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2018

Subject(s):

Carcinogenicity Tests -- standards
Carcinogens
Chemistry, Pharmaceutical
DNA Damage -- genetics
Drug Contamination -- prevention & control
Mutagenicity Tests -- standards
Mutagens
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

20. Bioanalytical method validation

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Drug Evaluation, Preclinical -- standards
Reproducibility of Results
Research Design -- standards
Validation Studies as Topic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

21. Assessing user fees under the biosimilar user fee amendments of 2017

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Biosimilar Pharmaceuticals -- economics
Fees and Charges
Investigational New Drug Application -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

22. Extension of certain tobacco product compliance deadlines related to the final deeming rule: (revised)

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Product Labeling -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

23. Elemental impurities in drug products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Chemistry, Pharmaceutical
Drug Contamination
Quality Control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

24. Dissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Chemistry, Pharmaceutical
Drug Liberation
Solubility
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

25. Japanese medical equipment (Number 168, January 24, 1946)

26. Japanese medical equipment (Number 171, January 31, 1946)

27. Insurance markets: health benefit costs : employers share the pain

Publication:

[Oakland, Calif.] : California HealthCare Foundation, [2003]

Subject(s):

Cost Sharing -- economics
Employer Health Costs
California

28. Impact of the 2004-05 May revision on health programs in California

Publication:

Oakland, Calif. : California HealthCare Foundation, c2004

Subject(s):

Health Expenditures
Managed Care Programs -- economics
Medicaid -- economics
California

29. Improving decision support tools for the long term care consumer

Publication:

Oakland, Calif. : California HealthCare Foundation, [2008]

Subject(s):

Community Participation
Databases, Factual
Decision Support Techniques
Long-Term Care
Patient Participation
California

30. Independent medical review experiences in California. Phase I, Cases of investigational/experimental treatments

Publication:

Oakland, Calif. : California HealthCare Foundation, c2002

Subject(s):

Health Maintenance Organizations -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
Patient Advocacy
California

31. How policy changes impact enrollment: a look at three county efforts

Author(s):

Chimento, Lisa.

Publication:

Oakland, Calif. : California HealthCare Foundation, c2004

Subject(s):

Insurance, Health -- legislation & jurisprudence
Insurance Coverage -- organization & administration
Health Policy
Medically Uninsured
Local Government
California

32. Implementing the Federal Health Privacy Rule in California: a guide for pharmacists, physical therapists, and others

Author(s):

Pritts, Joy.

Publication:

[Oakland, Calif.] : California HealthCare Foundation, c2002

Subject(s):

Confidentiality -- legislation & jurisprudence
Forms and Records Control -- legislation & jurisprudence
Medical Records -- legislation & jurisprudence
California
United States.

33. Improving access to health care in California: testing new roles for providers

Author(s):

Dower, Catherine

Publication:

Oakland, Calif. : California HealthCare Foundation, [2009]

Subject(s):

Allied Health Personnel
Health Services Accessibility
Health Workforce
Role
California

34. The impact of federal stimulus funds on community health centers in California

Publication:

[Oakland, Calif.] : California HealthCare Foundation, [2009]

Subject(s):

Community Health Centers -- economics
Community Health Centers -- legislation & jurisprudence
Community Networks -- economics
Community Networks -- legislation & jurisprudence
Financing, Government -- economics
Financing, Government -- legislation & jurisprudence
California
United States

35. Is there a doctor in the house?: physician liability fears and quality of care in nursing homes

Author(s):

Kapp, Marshall B.

Publication:

Oakland, Calif. : California HealthCare Foundation, [2008]

Subject(s):

Attitude of Health Personnel
Defensive Medicine
Fear
Liability, Legal
Nursing Homes
Physicians -- psychology
California
United States

36. Facility definition under Section 503B of the Federal Food, Drug, and Cosmetic Act

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Drug Compounding -- standards
Drug Industry -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

37. Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 13, 2018

Subject(s):

Genetic Testing
Germ-Line Mutation
Diagnostic Test Approval
Reagent Kits, Diagnostic -- standards
Sequence Analysis, DNA
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

38. Clinical trial imaging endpoint process standards

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2018

Subject(s):

Clinical Trials as Topic -- standards
Diagnostic Imaging -- standards
Endpoint Determination -- standards
Research Design -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

39. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, July 2018

Subject(s):

Blood Component Transfusion
Blood Safety -- standards
Blood Transfusion
Zika Virus Infection -- blood
Zika Virus Infection -- transmission
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

40. Labeling for biosimilar products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Biosimilar Pharmaceuticals
Drug Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

41. Nonallergic rhinitis: developing drug products for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2018

Subject(s):

Clinical Trials as Topic
Drug Evaluation
Rhinitis -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

42. Japanese medical equipment (Number 152, December 27, 1945)

43. Japanese medical equipment (Number 170, January 29, 1946)

44. Creating better systems of care for adults with disabilities: lessons for policy and practice

Author(s):

Hostetter, Martha, author
Klein, Sarah, author

Publication:

[New York, N.Y.] : Commonwealth Fund, September 2018

Subject(s):

Persons with Disabilities -- rehabilitation
Health Services Accessibility
Health Services for Persons with Disabilities
Health Services Needs and Demand
Intellectual Disability -- rehabilitation
Intellectual Disability -- therapy
Mental Disorders -- rehabilitation
Mental Disorders -- therapy
Social Support
Florida
Minnesota
New York City
Pennsylvania
Tennessee
United States

45. Japanese medical equipment (Number 172, February 8, 1946)

46. Japanese medical equipment (Number 174, February 12, 1946)

47. Implementing the Federal Health Privacy Rule in California: a guide for health care providers

Author(s):

Pritts, Joy.

Publication:

[Oakland, Calif.] : California Healthcare Foundation, c2002

Subject(s):

Confidentiality -- legislation & jurisprudence
Forms and Records Control -- legislation & jurisprudence
Medical Records -- legislation & jurisprudence
California

48. Registration and product listing for owners and operators of domestic tobacco product establishments: (revised)

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Registries -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

49. Health document submission requirements for tobacco products: (revised)

Publication:

Silver Spring, MD : Center for Tobacco Products, October 2017

Subject(s):

Documentation -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

50. E18 genomic sampling and management of genomic data

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2018

Subject(s):

Data Collection -- standards
Genomics -- standards
Specimen Handling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

51. Implementing national health reform in California: opportunities for improved access to care

Publication:

[Oakland, Calif.] : California HealthCare Foundation, c2011

Subject(s):

Health Care Reform -- legislation & jurisprudence
Health Services Accessibility -- legislation & jurisprudence
California
United States
United States.

52. Listing of ingredients in tobacco products: (revised)

Publication:

Silver Spring, MD : Center for Tobacco Products, Food and Drug Administration, April 2018

Subject(s):

Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

53. Establishing effectiveness for drugs intended to treat male hypogonadotropic hypogonadism attributed to nonstructural disorders

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Clinical Trials as Topic -- standards
Drug Evaluation -- standards
Endpoint Determination
Hypogonadism -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

54. Logical observation identifiers names and codes for in vitro diagnostic tests: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, June 15, 2018

Subject(s):

Logical Observation Identifiers Names and Codes
Electronic Health Records
Health Information Interoperability
Reagent Kits, Diagnostic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

55. Complicated urinary tract infections: developing drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Anti-Bacterial Agents -- therapeutic use
Anti-Infective Agents, Urinary -- therapeutic use
Clinical Trials as Topic -- standards
Drug Evaluation
Microbiological Techniques -- standards
Urinary Tract Infections -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

56. S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Antineoplastic Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

57. Medical product communications that are consistent with the FDA-required labeling: questions and answers

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Communication
Drug Labeling -- standards
Product Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

58. ANDA submissions--amendments to abbreviated new drug applications under GDUFA

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Drugs, Generic -- standards
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

59. Use of electronic health record data in clinical investigations

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Clinical Trials as Topic
Electronic Health Records -- statistics & numerical data
Health Information Interoperability
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

60. Quality attribute considerations for chewable tablets

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Chemistry, Pharmaceutical
Drug Liberation
Mastication
Quality Control
Solubility
Tablets -- pharmacokinetics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

61. Microdose radiopharmaceutical diagnostic drugs: nonclinical study recommendations

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Drug Evaluation, Preclinical
Radiopharmaceuticals -- administration & dosage
Radiopharmaceuticals -- pharmacokinetics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

62. Japanese medical equipment (Number 151, December 27, 1945)

63. E17 general principles for planning and design of multiregional clinical trials

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Clinical Trials as Topic
Drug Evaluation
Research Design
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

64. Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Communication
Equipment and Supplies -- economics
Insurance, Health, Reimbursement -- economics
Pharmaceutical Preparations -- economics
Truth Disclosure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

65. Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases

Publication:

Silver Spring, MD : Office of Orphan Products Development, Food and Drug Administration, July 2018

Subject(s):

Drug Approval
Orphan Drug Production
Pediatrics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

66. Physiologically based pharmacokinetic analyses--format and content

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Drug Evaluation, Preclinical
Drugs, Investigational -- pharmacokinetics
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

67. Allergic rhinitis: developing drug products for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2018

Subject(s):

Drug Evaluation
Rhinitis, Allergic -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

68. Japanese medical equipment

Publication:

[Tokyo?] : Medical Analysis Section, 5250th Technical Intelligence Company, -18 March 1946

Subject(s):

Military Medicine -- instrumentation
Medicine Chests
Japan
Japan. Rikugun

69. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 14, 2018

Subject(s):

Clinical Trials as Topic
Consensus
Device Approval
Equipment and Supplies -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

70. Japanese medical equipment (Number 169, January 28, 1946)

71. How would state-based individual mandates affect health insurance coverage and premium costs?

Author(s):

Blumberg, Linda J., author
Buettgens, Matthew, author
Holahan, John, author

Publication:

[New York, N.Y.] : Commonwealth Fund, July 2018

Subject(s):

Health Insurance Exchanges -- economics
Health Insurance Exchanges -- statistics & numerical data
Insurance Coverage -- economics
Insurance Coverage -- statistics & numerical data
Insurance, Health -- economics
Insurance, Health -- statistics & numerical data
Mandatory Programs -- economics
Medically Uninsured -- statistics & numerical data
State Government
United States
United States.
State Children's Health Insurance Program (U.S.)

72. Japanese medical equipment (Number 173, February 25, 1946)

73. Migraine: developing drugs for acute treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, February 2018

Subject(s):

Clinical Trials as Topic
Drug Evaluation -- standards
Migraine Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

74. In or out: an examination of Medicaid's coverage determination policies

Author(s):

Manatt, Phelps & Phillips. Manatt Health Solutions, author.

Publication:

[Oakland, Calif.] : California HealthCare Foundation, August 2015

Subject(s):

Eligibility Determination
Insurance Coverage
Medicaid
Organizational Policy
United States

75. Use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics: guidance for stakeholders and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, April 13, 2018

Subject(s):

Databases, Genetic
Reagent Kits, Diagnostic -- standards
Reproducibility of Results
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

76. Q7 good manufacturing practice guidance for active pharmaceutical ingredients: questions and answers

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2018

Subject(s):

Chemistry, Pharmaceutical -- standards
Pharmaceutical Preparations -- standards
Quality Control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

77. How much is too much?: an analysis of health plan profits and administrative costs in California

Publication:

Oakland, Calif. : California HealthCare Foundation, [2008]

Subject(s):

Health Care Costs
Insurance Carriers -- economics
Insurance Carriers -- legislation & jurisprudence
California
United States

78. Improving the patient experience: best practices for safety-net clinic redesign

Author(s):

Joseph, Anjali.

Publication:

Oakland, Calif. : California HealthCare Foundation, c2009

Subject(s):

Facility Design and Construction
Health Facility Environment
Patient Satisfaction
Patient-Centered Care
California

79. Regulatory classification of pharmaceutical co-crystals

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, February 2018

Subject(s):

Chemistry, Pharmaceutical -- classification
Chemistry, Pharmaceutical -- standards
Crystallization -- classification
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

80. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Fees and Charges
Investigational New Drug Application -- economics
Prescription Drugs -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

81. How to prepare a pre-request for designation (pre-RFD)

Publication:

[Silver Spring, Maryland] : Office of Combination Products, Office of the Commissioner, February 2018

Subject(s):

Equipment and Supplies -- classification
Drugs, Investigational -- classification
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

82. Health and safety code (1963)

83. Resident training program of the medical service, Brooke General Hospital: lectures, seminars, and diagnostic conferences

Author(s):

Brooke General Hospital, author.

Publication:

[Fort Sam Houston, Texas] : Brooke General Hospital, [1947- ]

Subject(s):

Hospitals, Military
Internship and Residency
Texas
Brooke General Hospital.

84. Resident training program of the medical service, Brooke General Hospital: lectures, seminars, and diagnostic conferences (Volume II, January 1-December 31, 1948)

85. Health and safety code (1959)

86. Health and safety code (1943)

87. Health and safety code (1945)

88. Public health and welfare in Japan (1949, Tables)

89. Public health and welfare in Japan (1950, Annual Summary, Volume I)

90. Health and safety code (1955)

91. Health and safety code (1951)

92. Health and safety code

Author(s):

California, enacting jurisdiction.

Publication:

Sacramento, California : Supervisor of Documents

Subject(s):

Public Health -- legislation & jurisprudence
California

93. Health and safety code (1939)

94. Resident training program of the medical service, Brooke General Hospital: lectures, seminars, and diagnostic conferences (Volume III, January 1-December 31, 1949)

95. Medic's

Author(s):

Station Hospital (Hendricks Field, Fla.) author.

Publication:

Sebring, Florida : Station Hospital, Hendricks Field, 1943-[1944?]

Subject(s):

Hospitals, Military
Military Medicine
Florida
Station Hospital (Hendricks Field, Fla.)

96. Medic's (Volume 1, Number 1, July, 1943)

97. Medic's (Volume 1, Number 8, May, 1944)

98. Medic's (Volume 1, Number 9, June, 1944)

99. Medic's (Volume 1, Number 10, July, 1944)

100. Lecciones de medicina legal aplicada à la legislación de la República Argentina (Volume 2)

Author(s):

Bialet Massé, Juan, 1846-1907 author

Publication:

Córdoba : Imp. de Obras "La Velocidad" de Agustin Villafañe, 1885

Subject(s):

Legislation, Medical
Argentina